NIH, National Eye Institute (NEI)
Bethesda, MD USA

Our News on Newswise

In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage

Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against...
29-Jun-2015 1:00 PM EDT

The Brain’s Autofocus System Helps Stabilize Vision Despite Motion

Antelopphoto.jpg

Much like the automatic focus of a camera, our eyes and brains must constantly recalibrate so that we can get a clear view of the changing—and always moving—world around us. Two studies funded by the National Eye Institute (NEI) show how the...
28-May-2015 9:05 AM EDT

NIH-Funded Study Points Way Forward for Retinal Disease Gene Therapy

LCAphoto.png

Leber congenital amaurosis (LCA) is an inherited disorder that causes vision loss starting in childhood. This is the latest report from an ongoing clinical trial of gene therapy for the disorder, funded by the National Eye Institute (NEI), part of...
30-Apr-2015 10:00 AM EDT

NIH Launches Research to Gaze Deeply Into Your Eyes

Five bold projects will develop new technology to noninvasively image cells of the eye in unprecedented detail. The National Eye Institute (NEI) announced the awards as part of its Audacious Goals Initiative. NEI has committed $3.8 million to the...
29-Apr-2015 10:15 AM EDT

Eylea Outperforms Other Drugs for Diabetic Macular Edema with Moderate or Worse Vision Loss

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse...
13-Feb-2015 11:30 AM EST

NEI Sets Stage for New Clinical Trial to Tackle Dry Eye

CreditPatrickWalderzak.jpg

National Eye Institute funded researchers launch an FDA-approved Phase I clinical trial to test the safety and efficacy of a novel drug called P-321 Ophthalmic Solution. The drug is applied as an eye drop and targets a unique mechanism involved in...
1-Oct-2014 11:10 AM EDT

Gene Profiling Technique to Accelerate Stem Cell Therapies for Eye Diseases

RPE.jpg

Researchers at the National Institutes of Health have developed a technique that will speed up the production of stem-cell derived tissues. The technique will help the researchers in their efforts to use patients’ skin cells to regenerate retinal...
16-Jul-2014 12:00 PM EDT

Rehabilitation Helps Prevent Depression From Age-Related Vision Loss

OTvisionclient.JPG

Depression is a common risk for people who have lost their vision from age-related macular degeneration (AMD), but a new study shows that a type of rehabilitation therapy can cut this risk in half.
7-Jul-2014 9:00 AM EDT

Our Experts on Newswise

Our YouTube Videos